Health tech funding rounds get bigger when Andreessen Horowitz and General Catalyst joinnews2026-01-14T18:43:51+00:00January 14th, 2026|Endpoints News|
#JPM26: Drugmakers want US reforms, not to slow down Chinanews2026-01-14T16:10:57+00:00January 14th, 2026|Endpoints News|
ImmunityBio’s Anktiva lung cancer data; Glaukos’ glaucoma implant sales disappointnews2026-01-14T16:08:20+00:00January 14th, 2026|Endpoints News|
Thermo Fisher to lay off 421 workers as it winds down lab product site in North Carolinanews2026-01-14T15:59:10+00:00January 14th, 2026|Endpoints News|
Caldera Therapeutics erupts with $112.5M and a China-originated IBD bispecificnews2026-01-14T12:00:39+00:00January 14th, 2026|Endpoints News|
#JPM26: Day 3 at the JP Morgan Healthcare Conferencenews2026-01-14T12:00:12+00:00January 14th, 2026|Endpoints News|
#JPM26: Q&A with Bristol Myers Squibb CEO Chris Boerner on 2026 outlooknews2026-01-14T11:45:48+00:00January 14th, 2026|Endpoints News|
FDA delays decision on expanding label for Travere’s kidney disorder drugnews2026-01-13T21:19:40+00:00January 13th, 2026|Endpoints News|
FDA requests flu vaccine label updates to include febrile seizure risknews2026-01-13T19:54:18+00:00January 13th, 2026|Endpoints News|
FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labelsnews2026-01-13T19:00:55+00:00January 13th, 2026|Endpoints News|
